title: Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway.
abstract: Recently, CXCL12-CXCR4 has been focused on therapeutic strategies for papillary thyroid carcinoma (PTC) and other cancers. At the same time, cell surface nucleolin is also over-expressed in PTC and others. Interestingly, a few reports suggest that either CXCR4 or cell surface nucleolin is a co-receptor for HIV-1 entry into CD4+ T cells, which indicates that there is a relationship between CXCR4 and nucleolin. In this study, antibody and siRNA were used to identify effects of cell surface nucleolin and CXCR4 on cell signaling; soft-agar colony formation assay and Transwell assay were used to determine roles of nucleolin and CXCR4 in cell proliferation and migration. Importantly, co-immunoprecipitation was used to demonstrate the relationship between CXCR4 and nucleolin. Results showed CXCR4 and nucleolin were co-expressed in PTC cell line K1, B-CPAP, and TPC-1. Either cell surface nucleolin or CXCR4 was necessary to prompt extracellular signal-regulated kinase phosphorylation. When blocked, CXCR4 or nucleolin can significantly affect TPC-1 proliferation and migration (p < 0.01). Co-immunoprecipitation analysis identified that nucleolin can bind and interact with CXCR4 to activate CXCR4 signaling. This study suggests that nucleolin is crucial in the activation of CXCR4 signaling, which affects cell growth, migration, and invasiveness. Further, nucleolin may interact with other receptors. Our study also offers new ideas for cancer therapy.
authors.affiliation: Department of Pathology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China, yangxiangshan163@163.com.
authors.forename: Xiangshan
authors.initials: X
authors.lastname: Yang
authors.forename: Zhongfa
authors.initials: Z
authors.lastname: Xu
authors.forename: Daotang
authors.initials: D
authors.lastname: Li
authors.forename: Shaomei
authors.initials: S
authors.lastname: Cheng
authors.forename: Kaixi
authors.initials: K
authors.lastname: Fan
authors.forename: Chengjun
authors.initials: C
authors.lastname: Li
authors.forename: Aiping
authors.initials: A
authors.lastname: Li
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: Man
authors.initials: M
authors.lastname: Feng
mesh_terms: D002277:Carcinoma / Q000235:genetics / Q000378:metabolism; D002291:Carcinoma, Papillary; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism*; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation; D054377:Chemokine CXCL12 / Q000378:metabolism*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D011485:Protein Binding; D016601:RNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D000077273:Thyroid Cancer, Papillary; D013964:Thyroid Neoplasms / Q000235:genetics / Q000378:metabolism; D000097796:Nucleolin
chemical_list: D054377:Chemokine CXCL12; D048049:Extracellular Signal-Regulated MAP Kinases; D010750:Phosphoproteins; D016601:RNA-Binding Proteins; D019718:Receptors, CXCR4; D000097796:Nucleolin
references.citation: Semin Immunol. 2003 Feb;15(1):49-55
references.pmid: 12495640
references.citation: J Biol Chem. 1999 Sep 24;274(39):27875-84
references.pmid: 10488134
references.citation: Innate Immun. 2012 Jun;18(3):478-91
references.pmid: 21994253
references.citation: Blood. 2002 Feb 1;99(3):785-91
references.pmid: 11806977
references.citation: J Neurooncol. 2012 May;108(1):59-67
references.pmid: 22382782
references.citation: BMC Cancer. 2008 Sep 30;8:274
references.pmid: 18826577
references.citation: FEBS J. 2006 Oct;273(20):4668-81
references.pmid: 16995858
references.citation: Proc Natl Acad Sci U S A. 1973 May;70(5):1316-20
references.pmid: 4351171
references.citation: Annu Rev Immunol. 2000;18:217-42
references.pmid: 10837058
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8
references.pmid: 14595012
references.citation: Cell Res. 2006 Feb;16(2):174-81
references.pmid: 16474431
references.citation: J Pathol. 2010 Nov;222(3):249-60
references.pmid: 20814900
references.citation: AIDS. 2012 Apr 24;26(7):887-90
references.pmid: 22313951
references.citation: Blood. 2007 Apr 1;109(7):3069-75
references.pmid: 17179226
references.citation: Leukemia. 2006 Nov;20(11):1915-24
references.pmid: 16900209
references.citation: Mol Biol Cell. 2003 Aug;14(8):3305-24
references.pmid: 12925765
references.citation: Biochem J. 2001 Dec 15;360(Pt 3):531-8
references.pmid: 11736641
references.citation: Thyroid. 2009 Sep;19(9):957-65
references.pmid: 19731977
references.citation: Cell. 2000 Oct 13;103(2):211-25
references.pmid: 11057895
references.citation: Gastroenterology. 2005 Oct;129(4):1237-50
references.pmid: 16230077
references.citation: Clin Cancer Res. 2011 Jun 1;17(11):3638-48
references.pmid: 21459800
references.citation: Nat Rev Cancer. 2004 Jul;4(7):540-50
references.pmid: 15229479
references.citation: Nature. 1996 Aug 29;382(6594):833-5
references.pmid: 8752281
references.citation: Immunity. 2000 Feb;12(2):121-7
references.pmid: 10714678
references.citation: J Biol Chem. 2001 Dec 7;276(49):45509-12
references.pmid: 11641392
references.citation: Mod Pathol. 2008 May;21 Suppl 2:S37-43
references.pmid: 18437172